Introduction
In the seventies the Food and Drug Administration (FDA) of the United States of America (USA) detected some cases of fraud involving data generated by toxicology labs which was submitted to the FDA by pharmaceutical companies. In a certain laboratory thousands of safety tests for chemical manufacturers were falsely claimed to have been performed or were of such poor quality that police investigators could not piece together what work had been done(1). The most important deficiencies encountered were:
